Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET COMMENT: Stocks Seen Lower; Ted Baker To Meet Forecasts

Fri, 12th Jun 2015 06:31

LONDON (Alliance News) - London share prices are set to open lower Friday, as confidence in a deal emerging from the Greek debt negotiations took a hit late Thursday, with stock indices across Europe giving back almost half of their earlier gains late in trading.

IG says futures indicate the FTSE 100 to open 25 points lower at 6,821.6. The index closed up 0.2% at 6,846.74 on Thursday, having reached a peak of 6,870.19.

The International Monetary Fund's technical team left bailout talks with Greece in Brussels and returned to Washington with the sides "well away from an agreement", IMF spokesman Gerry Rice said Thursday.

"There are major differences between us in most key areas," according to Rice. "There has been no progress in narrowing these differences recently."

The IMF spokesman noted the "urgency" of the talks, but he added there is "no real schedule here" for negotiations. "The IMF never leaves the table," Rice said. "We remain engaged, but the ball is very much in Greece's court right now."

CMC Markets UK chief market analyst Michael Hewson comments: "The logjam appears to revolve around pension and labour market reform, which Greece remains unwilling to compromise on, and when looking at the demonstrations that took place back in Athens yesterday it?s not hard to see why."

"Even if Greece does compromise on the issues the IMF wants change on, there is no guarantee that they would be able to implement them and therein lies the rub," writes Hewson.

Despite the IMF's leaving, Greece's State Minister Alekos Flabouraris was optimistic talking to Greek television ERT, Reuters reported Friday.

"I hope [a deal] will come very soon, on June 18, when the Eurogroup takes place," said Flabouraris.

Lloyds Bank economist Rhys Herbert agrees: "We treat the June 18 [Eurogroup meeting] as the deal-maker date as the meetings over the past three days confirmed the strong political will for an agreement as soon as possible."

Wall Street ended higher Thursday. The DJIA and the S&P 500 ended up 0.2% and the Nasdaq Composite closed up 0.1%.

In Asia on Friday, the Japanese Nikkei 225 closed up 0.1%. Meanwhile, the Hang Seng trades up 0.6% and the Shanghai Composite is up 1.0%.

Japan's industrial production climbed more than initially estimated in April, latest figures from the Ministry of Economy, Trade and Industry showed Friday. Industrial production rose a seasonally adjusted 1.2% month-over-month in April, revised up from a 1.0% gain in the flash data. It was the first increase in three months. In March, production had fallen 0.8%.

In the corporate front, fashion retailer Ted Baker Friday said it is on track to meet expectations for its full year following a strong start, with revenue up 24.2% in the eighteen weeks from the beginning of February to June 6.

Retail sales during the period were up 18.9%, or 18.1% at constant currency, the company said. E-commerce sales rose 46.9%, driven by further growth in the UK and a strong performance from Ted Baker's US site, as well as a contribution from its new Canadian site launched at the end of 2014.

GlaxoSmithKline said the Pulmonary Allergy Drugs Advisory Committee of the US Food and Drug Administration voted unanimously that efficacy and safety data for mepolizumab supported its approval for adults aged 18 or older with severe asthma.

Meanwhile, Royal Dutch Shell has notified Ukraine that it will pull out of a shale gas exploration project in the east of the country, the Financial Times reported Thursday, as a result of the ongoing conflict in the region.

Insiders cited heightened geopolitical risk and sharp drop in global oil prices, which has made shale gas exploration projects less attractive, the report says.

In a light economic calendar Friday, eurozone industrial production is due at 1000 BST. In the US, producer price index is due at 1330 BST, while Reuters/Michigan consumer sentiment index is due at 1500 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.